''REG3BETA DEFICIENCY IMPAIRS PANCREATIC TUMOR GROWTH BY SKEWING MACROPHAGE POLARIZATION.''
''PROTEASOME INHIBITORS PROTECT THE STEATOTIC AND NON-STEATOTIC LIVER GRAFT AGAINST COLD ISCHEMIA REPERFUSION INJURY.''
''ATTENUATION OF ENDOPLASMIC RETICULUM STRESS AND MITOCHONDRIAL INJURY IN KIDNEY WITH ISCHEMIC POSTCONDITIONING APPLICATION AND TRIMETAZIDINE TREATMENT.''
''IGL-1 SOLUTION REDUCES ENDOPLASMIC RETICULUM STRESS AND APOPTOSIS IN RAT LIVER TRANSPLANTATION.''
''ISCHEMIC PRECONDITIONING REDUCES ENDOPLASMIC RETICULUM STRESS AND UPREGULATES HYPOXIA INDUCIBLE FACTOR-1? IN ISCHEMIC KIDNEY: THE ROLE OF NITRIC OXIDE.''
''UBIQUITIN-PROTEASOME SYSTEM INHIBITORS AND AMPK REGULATION IN HEPATIC COLD ISCHAEMIA AND REPERFUSION INJURY: POSSIBLE MECHANISMS.''
''THE USE OF A REVERSIBLE PROTEASOME INHIBITOR IN A MODEL OF REDUCED-SIZE ORTHOTOPIC LIVER TRANSPLANTATION IN RATS.''
''HOW TO PROTECT LIVER GRAFT WITH NITRIC OXIDE.''
''HOW INSTITUT GEORGES LOPEZ PRESERVATION SOLUTION PROTECTS NONSTEATOTIC AND STEATOTIC LIVERS AGAINST ISCHEMIA-REPERFUSION INJURY.''
''MELATONIN PROTECTS STEATOTIC AND NONSTEATOTIC LIVER GRAFTS AGAINST COLD ISCHEMIA AND REPERFUSION INJURY.''
''MELATONIN PROLONGS GRAFT SURVIVAL OF PANCREAS ALLOTRANSPLANTS IN PIGS.''
"ROLE OF OXIDATIVE STRESS AND ADENOSINE NUCLEOTIDES IN THE LIVER OF AGING RATS."
"ADDITION OF CARVEDILOL TO UNIVERSITY WISCONSIN SOLUTION IMPROVES RAT STEATOTIC AND NONSTEATOTIC LIVER PRESERVATION."
"MATRIX METALLOPROTEINASE 2 IN REDUCED-SIZE LIVER TRANSPLANTATION: BEYOND THE MATRIX."
"INSULIN LIKE GROWTH FACTOR-1 INCREASES FATTY LIVER PRESERVATION IN IGL-1 SOLUTION."
"IMPROVED RAT STEATOTIC AND NONSTEATOTIC LIVER PRESERVATION BY THE ADDITION OF EPIDERMAL GROWTH FACTOR AND INSULIN-LIKE GROWTH FACTOR-I TO UNIVERSITY OF WISCONSIN SOLUTION."
"HYPOXIA INDUCIBLE FACTOR-1ALPHA ACCUMULATION IN STEATOTIC LIVER PRESERVATION: ROLE OF NITRIC OXIDE."
"PHARMACOLOGICAL STRATEGIES AGAINST COLD ISCHEMIA REPERFUSION INJURY."
"NEW INSIGHTS INTO FATTY LIVER PRESERVATION USING INSTITUTE GEORGES LOPEZ PRESERVATION SOLUTION."
ARE ANGIOTENSIN II RECEPTOR ANTAGONISTS USEFUL STRATEGIES IN STEATOTIC AND NONSTEATOTIC LIVERS IN CONDITIONS OF PARTIAL HEPATECTOMY UNDER ISCHEMIA-REPERFUSION?